Intravitreal bevacizumab treatment for severe retinopathy of prematurity
Not Applicable
- Conditions
- severe retinopathy of prematurity
- Registration Number
- JPRN-UMIN000018122
- Lead Sponsor
- The Jikei University School of Medicine Department of Ophthalmology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with retinopathy of prematurity which are treatable by laser therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method